Current challenges and future prospects in oral anticoagulant therapy.

about

Evolving cardiovascular uses of direct-acting oral anticoagulants: a paradigm shift on the horizon?Effect of ABCB1 genetic polymorphisms on the transport of rivaroxaban in HEK293 recombinant cell lines.

P2860

Q38635568-D5B231ED-0290-4C75-B3CA-35890D4EEFE2 Q55662488-E01DD8CD-423F-429D-893A-2A2BF61EE140

P2860

Current challenges and future prospects in oral anticoagulant therapy.

Item

http://www.wikidata.org/entity/Q38675822

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Current challenges and future prospects in oral anticoagulant therapy.

@en

type

Item

label

Current challenges and future prospects in oral anticoagulant therapy.

@en

prefLabel

Current challenges and future prospects in oral anticoagulant therapy.

@en

P1476

Current challenges and future prospects in oral anticoagulant therapy.

@en

P2093

Jignesh P Patel

http://www.w3.org/2001/XMLSchema#string

Roopen Arya

http://www.w3.org/2001/XMLSchema#string

P2860

Use of Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Lesions

DOACs - advances and limitations in real world

Guidance for the management of venous thrombosis in unusual sites

Risk-Benefit Profile of Direct-Acting Oral Anticoagulants in Established Therapeutic Indications: An Overview of Systematic Reviews and Observational Studies

Efficacy and Harms of Direct Oral Anticoagulants in the Elderly for Stroke Prevention in Atrial Fibrillation and Secondary Prevention of Venous Thromboembolism: Systematic Review and Meta-Analysis

Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer

Dabigatran versus warfarin in patients with atrial fibrillation

Idarucizumab for Dabigatran Reversal

Dabigatran versus warfarin in patients with mechanical heart valves

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation

P304

838-851

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/BJH.14714

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

178

http://www.w3.org/2001/XMLSchema#string

P50

Julia Czuprynska

P577

2017-06-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28573648

http://www.w3.org/2001/XMLSchema#string

P921

anticoagulation

Current challenges and future prospects in oral anticoagulant therapy.

about

P2860

P2860

Current challenges and future prospects in oral anticoagulant therapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921